The global closed system transfer devices market will touch USD 3,516 million by 2030, advancing at a CAGR of 15.20% during 2022–2030. This growth can be credited to the growing need for CSTDs to confront the damaging effects of medications including antineoplastic or cytotoxic agents utilized to treat cancer, hormone agents, bioengineered drugs, and hormone agents. Oncology drugs are the … Continua a leggere→